There are bacteria that blink on and off like Christmas tree lights and bacteria that form multicolored patterns of concentric circles resembling an archery target. Yet others can reproduce photographic images.
These are not strange-but-true specimens from nature, but rather the early tinkering of synthetic biologists, scientists who seek to create living machines and biological devices that can perform novel tasks.
"We want to do for biology what Intel does for electronics," said George Church, a professor of genetics at Harvard and a leader in the field. "We want to design and manufacture complicated biological circuitry."
PHOTOS: NY TIMES NEWS SERVICE
While much of the early work has consisted of eye-catching, if useless, stunts like the blinking bacteria, the emerging field could one day have a major impact on medicine and industry.
For instance, Christina Smolke, an assistant professor at the California Institute of Technology, is trying to develop circuits of biological parts to sit in the body's cells and guard against cancer. If they detected a cancer-causing mechanism had been activated, they would switch on a gene to have the cell self-destruct.
Jay Keasling at the University of California is trying to take up to 12 genes from the wormwood tree and yeast and get them to work together in E. coli bacteria to produce artemisinin, a malaria drug now extracted from the wormwood tree.
Craig Venter, the maverick scientist who sequenced the human genome, wants to create microbes that produce hydrogen for use as fuel.
To be sure, scientists have been putting genes into bacteria and other cells for three decades. The term "synthetic biology" seems to include various activities, some of which are not altogether new.
"This has a catchy new name, but anybody over 40 will recognize it as good old genetic engineering applied to more complex problems," said Frances Arnold, a professor of chemical engineering at Caltech.
Some synthetic biologists say they will go beyond genetic engineering, which often involves putting a single foreign gene into a cell. The human insulin gene, for instance, is put into bacteria, which then make insulin for use as a drug. But there have been genetic engineering projects involving multiple genes, so the number of genes alone is not enough to define synthetic biology.
Rather, the difference seems more about mind-set. "We're talking about taking biology and building it for a specific purpose, rather than taking existing biology and adapting it," Keasling of Berkeley said. "We don't have to rely on what nature's necessarily created."
Also new is an engineering approach -- the desire to make the design of life forms more predictable, like the design of a bridge. That could be because many leaders of the field are not biologists by training.
Ron Weiss of Princeton is a computer scientist. Michael Elowitz of Caltech trained as a physicist, and Drew Endy of the Massachusetts Institute of Technology as a structural engineer. Endy and colleagues at MIT have started a Registry of Standard Biological Parts. The parts, called BioBricks, are strings of DNA that can perform certain functions like turning on a gene or causing a cell to light up.
In theory at least, these components can be strung together to build more complex devices, just as an electronic engineer might put together transistors, resistors and oscillators to build a circuit. Scientists at the University of California, San Francisco, and the University of Texas used some BioBricks to engineer bacteria so that a sheet of them could capture an image as photographic film does. The microbes were altered so that those kept in the dark produced a black pigment while those exposed to light did not.
Some scientists envision that biological engineers will one day sit at computers writing programs for cells, like software developers. But the code would be written in sequences of DNA, rather than computer language. When finished, the programmer would press the "print" button, as it were, and the DNA would be made to order.
The field is also starting to attract some investment. In June, venture capitalists put US$13 million into Codon Devices, a startup company in Cambridge, Massachusetts, that is developing a way to synthesize long stretches of DNA far less expensively than existing methods. The founders include Church, Endy and Keasling.
Keasling is also a co-founder of Amyris Biotechnologies, which is helping make the malaria drug. And Venter has started Synthetic Genomics to work on his energy-producing microbes.
What makes the engineering approach possible are the inner workings of a living cell. Genes, made of DNA, contain the instructions for producing proteins, which carry out most functions in cells. Some proteins can bind to DNA, turning partic-ular genes on or off. This interplay, which is one way that cells regulate themselves, is not too different from how electronic circuits function, with one transistor turning another on or off.
Some newer efforts involve trying to manipulate entire colonies of microbes to cooperate with one another. They take
advantage of something called quorum sensing, a natural communications system that bacteria use to determine whether there are enough of them present to mount an attack.
The demonstrations, however clever, also illustrate problems inherent in designing biological circuits, as opposed to silicon ones. One is that living things are always dividing and evolving.
Indeed, the population-control system breaks down within days because some of the bacteria mutate so that the suicide gene is not switched on.
Those bacteria, having a selective advantage, quickly take over the colony, said Lingchong You, lead researcher on the
project at Caltech and now an assistant professor of biomedical engineering at Duke.
May 6 to May 12 Those who follow the Chinese-language news may have noticed the usage of the term zhuge (豬哥, literally ‘pig brother,’ a male pig raised for breeding purposes) in reports concerning the ongoing #Metoo scandal in the entertainment industry. The term’s modern connotations can range from womanizer or lecher to sexual predator, but it once referred to an important rural trade. Until the 1970s, it was a common sight to see a breeder herding a single “zhuge” down a rustic path with a bamboo whip, often traveling large distances over rugged terrain to service local families. Not only
Ahead of incoming president William Lai’s (賴清德) inauguration on May 20 there appear to be signs that he is signaling to the Chinese Communist Party (CCP) and that the Chinese side is also signaling to the Taiwan side. This raises a lot of questions, including what is the CCP up to, who are they signaling to, what are they signaling, how with the various actors in Taiwan respond and where this could ultimately go. In the last column, published on May 2, we examined the curious case of Democratic Progressive Party (DPP) heavyweight Tseng Wen-tsan (鄭文燦) — currently vice premier
The last time Mrs Hsieh came to Cihu Park in Taoyuan was almost 50 years ago, on a school trip to the grave of Taiwan’s recently deceased dictator. Busloads of children were brought in to pay their respects to Chiang Kai-shek (蔣中正), known as Generalissimo, who had died at 87, after decades ruling Taiwan under brutal martial law. “There were a lot of buses, and there was a long queue,” Hsieh recalled. “It was a school rule. We had to bow, and then we went home.” Chiang’s body is still there, under guard in a mausoleum at the end of a path
Last week the Directorate-General of Budget, Accounting and Statistics (DGBAS) released a set of very strange numbers on Taiwan’s wealth distribution. Duly quoted in the Taipei Times, the report said that “The Gini coefficient for Taiwanese households… was 0.606 at the end of 2021, lower than Australia’s 0.611, the UK’s 0.620, Japan’s 0.678, France’s 0.676 and Germany’s 0.727, the agency said in a report.” The Gini coefficient is a measure of relative inequality, usually of wealth or income, though it can be used to evaluate other forms of inequality. However, for most nations it is a number from .25 to .50